Taro Pharmaceutical Industries Ltd (NYSE:TARO)

74.19
Delayed Data
As of May 14
 +0.24 / +0.32%
Today’s Change
53.95
Today|||52-Week Range
80.00
+1.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$3.0B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 2624761
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Other institutional7.48%
Mutual fund holders5.89%
Individual stakeholders11.85%

Top Executives

Uday Vijaykumar BaldotaChief Executive Officer & Director
Itamar KarsentiVice President & Head-Operations
Daphne Yan HuangVP, Chief Financial & Accounting Officer
Avi AvramoffVice President & Head-Research & Development
Richard GlazeVice President & Head-Information Technology